NAL PHARMACEUTICAL GROUP LIMITED – Trademark Portfolio
Entity Type: 99
NAL PHARMACEUTICAL GROUP LIMITED holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include ACE KING, LIDO KING, and NAL PHARMA. The owner is based in HONG KONG.
311 GLOUCESTER ROAD, CAUSEWAY BAY
ROOM 2109 WINDSOR HOUSE
HONG KONG , HK
Showing of trademarks Trademarks
Trademark Classifications
NAL PHARMACEUTICAL GROUP LIMITED's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does NAL PHARMACEUTICAL GROUP LIMITED have?
NAL PHARMACEUTICAL GROUP LIMITED has 8 U.S. trademarks filed with the USPTO. Of these, 6 registered, 1 abandoned, 1 cancelled.
What trademark classes does NAL PHARMACEUTICAL GROUP LIMITED file in?
NAL PHARMACEUTICAL GROUP LIMITED files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are NAL PHARMACEUTICAL GROUP LIMITED's most well-known trademarks?
NAL PHARMACEUTICAL GROUP LIMITED's registered trademark portfolio includes well-known marks such as ACE KING, LIDO KING, and NAL PHARMA. These are among 6 currently registered trademarks in the portfolio.
What is NAL PHARMACEUTICAL GROUP LIMITED's trademark registration success rate?
NAL PHARMACEUTICAL GROUP LIMITED has a 75% trademark registration rate, with 6 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.